Dark

XTNT
Xtant Medical Holdings, Inc.
stock NYSEAMERICAN

At Close

Aug 7, 2026

0.4442USD+0.339%(+0.0015)31,448

0.00Bid 0.00Ask 0.0000Spread

Pre-market

0.00USD-100.000%(-0.44)0

After-hours

Aug 7, 2026 4:06:30 PM EDT

0.4477USD-2.832%(+0.4477)1,267

OverviewHistoricalExchangesShortsNews

Jan 4, 2022

08:00AM EST Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, Chief Executive Officer, will present at the H.C. Wainwright BioConnect Virtual Conference taking place January 10-13, 2022. GlobeNewswire Inc

Jan 3, 2022

08:44AM EST Xtant Medical Appoints Scott Neils As Interim CFO RTTNews

08:03AM EST Xtant Medical Appoints Scott Neils Interim Chief Financial Officer Benzinga

08:00AM EST Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the appointment of Scott Neils as Interim Chief Financial Officer succeeding Greg Jensen, the Companys current Vice President, Finance and Chief Financial Officer, effective January 3, 2022. GlobeNewswire Inc

Nov 12, 2021

07:47AM EST The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares Benzinga

07:27AM EST Xtant Medical Holdings, Inc. Common Stock Q3 EPS $(0.02) Up From $(0.10) YoY, Sales $13.78M Miss $14.02M Estimate Benzinga

07:00AM EST Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the third quarter ended September 30, 2021. GlobeNewswire Inc

04:26AM EST Earnings Scheduled For November 12, 2021 Benzinga

Nov 5, 2021

08:30AM EDT Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the third quarter ended September 30, 2021, before the open of the financial markets on Friday, November 12, 2021. GlobeNewswire Inc

Oct 19, 2021

08:00AM EDT Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, honors Samuel Lee Becker, a donor hero, as part of its sponsorship of the 2022 Donate Life Float at the Rose Parade in Pasadena on New Years Day. GlobeNewswire Inc

Sep 7, 2021

08:00AM EDT Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, Chief Executive Officer, will present at the H.C. Wainwright 23rd Annual Global Investment Conference to be held September 13 - 15, 2021. GlobeNewswire Inc

Aug 5, 2021

07:43AM EDT Xtant Medical Holdings, Inc. Common Stock Q2 EPS $(0.01) Up From $(0.19) YoY, Sales $15.00M Beat $14.02M Estimate Benzinga

07:00AM EDT Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the second quarter ended June 30, 2021. GlobeNewswire Inc

04:08AM EDT Earnings Scheduled For August 5, 2021 Benzinga

May 13, 2021

08:00AM EDT Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, Chief Executive Officer, will present at the Canaccord Musculoskeltal Conference on Thursday, May 20, 2021, at 3:00 PM Eastern Time. GlobeNewswire Inc

May 11, 2021

12:47PM EDT Earnings Scheduled For May 11, 2021 Benzinga

07:54AM EDT The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings Benzinga

07:41AM EDT Xtant Medical Holdings, Inc. Common Stock Q1 Sales $12.54M Miss $14.02M Estimate Benzinga

07:05AM EDT Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the first quarter ended March 31, 2021. GlobeNewswire Inc

07:00AM EDT Xtant Medical Files $150 Million Shelf Registration Statement GlobeNewswire Inc

04:14AM EDT Earnings Scheduled For May 11, 2021 Benzinga

May 6, 2021

04:57PM EDT Xtant Medical Announces $20M Debt Financing with MidCap Financial Benzinga

May 4, 2021

08:30AM EDT Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the first quarter ended March 31, 2021, before the open of the financial markets on Tuesday, May 11, 2021. GlobeNewswire Inc

Apr 12, 2021

10:16AM EDT Mid-Morning Market Update: Markets Open Lower; Microsoft To Acquire Nuance Benzinga

Apr 6, 2021

05:30PM EDT Xtant Medical Holdings Files For Resale Of Up To 16M Shares By Selling Stockholders Benzinga

Feb 26, 2021

04:08PM EST Xtant Medical Comments On Trading Activity Of Its Stock Says Not Aware Of Any Material, Undisclosed Corporate Developments Or Material Change In Its Business Or Affairs Benzinga

04:05PM EST Xtant Medical Comments on Trading Activity of its Stock GlobeNewswire Inc

11:39AM EST OrbiMed Reports In 13D Filing A 94.8% Stake In Xtant, Raising Stake By ~7,000 Shares Benzinga

Feb 25, 2021

08:30AM EST Xtant Medical Announces Closing of $20 million Private placement GlobeNewswire Inc

Feb 24, 2021

07:30AM EST The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO Benzinga

07:10AM EST Xtant Medical Holdings, Inc. Common Stock Q4 EPS $(0.01) Up From $(0.12) YoY, Sales $14.00M Miss $17.47M Estimate Benzinga

07:06AM EST Xtant Medical Holdings, Inc. Common Stock Q4 EPS $(0.01) Up From $(0.12) YoY, Adj. EBITDA $1.1M, Sales $14.00M Miss $17.47M Estimate Benzinga

07:00AM EST Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the fourth quarter and year ended December 31, 2020. GlobeNewswire Inc

03:35AM EST Earnings Scheduled For February 24, 2021 Benzinga

Feb 22, 2021

08:38AM EST Xtant Medical Prices 8.89M Share, Warrant Private Placement At $2.25/Share Benzinga

08:30AM EST Xtant Medical Announces $20 Million Private Placement GlobeNewswire Inc

Feb 17, 2021

08:30AM EST Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2020, before the open of the financial markets on Wednesday, February 24, 2021. GlobeNewswire Inc

Dec 7, 2020

08:30AM EST Xtant Medical Announces Expiration of Rights Offering GlobeNewswire Inc

Oct 29, 2020

07:53AM EDT Xtant Medical Holdings, Inc. Common Stock Q3 EPS $(0.10) Beats $(0.11) Estimate, Sales $14.02M Miss $16.03M Estimate Benzinga

07:30AM EDT The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal Benzinga

07:01AM EDT Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the third quarter ended September 30, 2020. GlobeNewswire Inc

04:08AM EDT Earnings Scheduled For October 29, 2020 Benzinga

Oct 22, 2020

04:10PM EDT Xtant Medical Announces Nov. 5 Record Date And Other Key Dates For Proposed $15 Million Rights Offering Benzinga

04:05PM EDT Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has set November 5, 2020 as the record date for its previously-announced proposed rights offering of up to $15 million of shares of its common stock and the expected subscription period. GlobeNewswire Inc

Oct 20, 2020

08:30AM EDT Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the third quarter ended September 30, 2020, before the open of the financial markets on Thursday, October 29, 2020. GlobeNewswire Inc

Oct 6, 2020

07:10AM EDT Xtant Medical Regains Compliance With NYSE American Continued Listing Standards RTTNews

07:00AM EDT Xtant Medical Regains Compliance with NYSE American Continued GlobeNewswire Inc

Oct 2, 2020

03:22PM EDT Mid-Afternoon Market Update: Dow Falls 50 Points; IDT Shares Climb After Q4 Results Benzinga

03:03PM EDT Mid-Day Market Update: Nasdaq Down 2%; American Renal Associates Shares Jump Benzinga

07:25AM EDT A Look Into Xtant Medical's Debt Benzinga

Oct 1, 2020

04:05PM EDT Xtant Medical Announces Closing Of Debt Restructuring Benzinga

04:05PM EDT Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has completed its previously announced debt restructuring transaction. GlobeNewswire Inc

Aug 24, 2020

08:30AM EDT Xtant Medical Announces U.S. Commercial Launch of the GlobeNewswire Inc

Aug 10, 2020

08:34AM EDT Xtant Medical Announces Debt Restructuring; Amendment Increases Number Of Authorized Shares From 75M To 300M Benzinga

08:30AM EDT Xtant Medical Announces Debt Restructuring GlobeNewswire Inc

Aug 3, 2020

04:16PM EDT Xtant Medical Holdings, Inc. Common Stock Q2 EPS $(0.19) Down From $(0.15) YoY, Sales $10.50M Down From $15.27M YoY Benzinga

04:06PM EDT Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the second quarter ended June 30, 2020. GlobeNewswire Inc